Daily Aspirin vs Split Dosing in High-risk Pregnancies (DASH)

PHASE1/PHASE2RecruitingINTERVENTIONAL

Enrollment

400

Participants

Timeline

Start Date

June 26, 2025

Primary Completion Date

July 1, 2029

Study Completion Date

December 31, 2029

Conditions

Preterm BirthPreeclampsia

Interventions

DRUG

Daily aspirin (ASA)

162mg aspirin taken daily

DRUG

Split dose aspirin (ASA)

81mg aspirin q12hours

Trial Locations (1)

RECRUITING

Thomas Jefferson University, Philadelphia

All Listed Sponsors

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Thomas Jefferson University

OTHER

NCT06826859 - Daily Aspirin vs Split Dosing in High-risk Pregnancies (DASH) | Biotech Hunter | Biotech Hunter